Transcript
Page 1: Flow of Patients Through the Trial

Flow of Patients Through the Trial

Steven E. Nissen, et al. JAMA 2006;295: Published online

Page 2: Flow of Patients Through the Trial

Baseline Patient Characteristics*

Steven E. Nissen, et al. JAMA 2006;295: Published online

Page 3: Flow of Patients Through the Trial

Laboratory Results (n = 346)*

Steven E. Nissen, et al. JAMA 2006;295: Published online

Page 4: Flow of Patients Through the Trial

Baseline and Follow-up Intravascular Ultrasound Results

Steven E. Nissen, et al. JAMA 2006;295: Published online

Page 5: Flow of Patients Through the Trial

Primary Efficacy Parameters in Prespecified Subgroups

Steven E. Nissen, et al. JAMA 2006;295: Published online

Page 6: Flow of Patients Through the Trial

Adverse Events, Drug Discontinuations, and Clinical

End Points in the Safety Population (N = 507)

Steven E. Nissen, et al. JAMA 2006;295: Published online

Page 7: Flow of Patients Through the Trial

Example of Regression of Atherosclerosis in a Patient in the Trial

Steven E. Nissen, et al. JAMA 2006;295: Published online

Page 8: Flow of Patients Through the Trial

Relationship Between Mean Low-Density Lipoprotein Cholesterol Levels and Median Change in Percent Atheroma Volume for Several Intravascular Ultrasound Trials

Steven E. Nissen, et al. JAMA 2006;295: Published online


Top Related